Multimorbidity is common and outcomes are poor among surgical patients across Europe. Addressing multimorbidity in elective and emergency patients requires innovative strategies to account for frailty and disease control. The development of such strategies, that integrate care targeting whole surgical pathways to strengthen current systems, is urgently needed for multimorbid patients. Interventional trials are warranted to determine the effectiveness of targeted management for surgical patients with multimorbidity.
Keyphrases
- patients undergoing
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- healthcare
- public health
- systematic review
- randomized controlled trial
- minimally invasive
- palliative care
- metabolic syndrome
- cardiovascular disease
- adipose tissue
- acute coronary syndrome
- patient reported outcomes
- coronary artery disease
- quality improvement
- skeletal muscle
- glycemic control